MF ac 1

NORSID CASE: Notorious Repeated Systemic Institutionalized Damages.

OPERATION MICROFLUITION: for preventive full mass non-symptomatic micro fluid testing, against anti/partial testing, post/anti symptomatic, adverse-drug-reaction/substance-abuse drug industries.

ACCUSATION: inclusion of accusation available for certified prosecutors and any citizen using email jusistem (at) jusistem.com; Notorious Repeated Systemic Institutionalized Damages.

Jusistem Investigation/Prosecution Operations are centered on Notorious Repeated Systemic Institutionalized Damages, involving general multiple parties on damaging/damaged sides that are initially not named, to set-up a CATO (Class Action Take Over), to protect/recover/prevent global damages to citizens, consumers, workers, investors and suppliers.

The process is open for contribution to global investigators, prosecutors, defenders and citizens to avoid common process fraud in national judicial systems, where in theory the judiciary should be independent but in practice, they are dependent of politicians financed by special interests of executive/legislative branches for budgets and promotions.

Jusistem decisions are served to other global judicial systems and to regional/national/local systems, for cooperation/coordination, with refusal to recognize global jurisdiction mandating the expedited execution of an alternative local process using the information given or new, all under the common interest of eliminating/recovering damages to citizens.

The “Operation Microfluition” and the “Operation Vaccination” focus on the attack on full microfluidic testing and vaccination as the process to eradicate diseases and reduce revenues of profiteering never-cured situation with partial-vaccination endemics and micro fluid testing to end substance abuse, collateral Adverse-Drug-Reaction and placebo-like drugs. The most important particular case involves the attack on Theranos/CEO Elizabeth Holmes by Pfizer/CEO then Chairman Ian Read and News Corporation/CEO than Chairman Rupert Murdoch.

Currently Theranos has been shut-down with Softbank taking its IP for US$100million while Elizabeth Holmes sits in a jail cell for a supposed 11 years, but not for long, since she is innocent and her persecutors are guilty. They attacked a legitimate dedicated enterprise/entrepreneur, Theranos/Elizabeth Holmes, in a crucial health sector, where vaccination/testing/supplementation can safe the millions of Human Lives while abusive monopolistic dominant chemical/pharma based market players are destroying Lives with inefficient technologies and trying to hijack efficient bio-medicine with inefficient processes susch as partial-vaccination, partial/post symptomatic testing. Meanwhile authentic pro-health bio-medical attempt to apply full coverage vaccination/testing.

Wrongful Theranos/Elizabeth Holmes destruction/imprisonment while the damaging parties think they have sailed into the sun-set profiting billions and even a supposed restitution of 125 million dollars for the supposed "investment" of News Corp/WSJ/Fox/Rupert Murdoch, a notorious sensationalist/partisan journalist and advertiser for Pfizer/CEO Ian Read 3 billion ad budget, Theranos competitor, 3 time attempted “partner”/acquirer, mainly because their best selling drug Lipitor was named on Theranos machine Patent as targeted for micro fluid Adverse Drug Reaction testing while Pfizer was facing a multi-billion class action lawsuit for diabetes collateral effects pointed out by FDA in 2012 and placebo-like effect on reducing cholesterol. Studies presented were deemed insufficient when it is the obligation of drug producers to follow up their low efficacy clinical trials with real world effectiveness tests in the short, medium and long term.

The Federal United States justice judgment, set-up by Lucy Koh (the Pfizer Zoloft statute of limitation judge), than passed on for sentencing to judge Edward Davila (the Wendy chili sauce 12 year in prison judge) to be reversed, will go down in history as something equivalent to condemning Little Red Riding Hood to 11 years of jail and to pay a 125 million fine to the big bad wolf (US$450 million total) for supposedly giving wrong information on grandma home, or supposed information fraud about a private business involving sophisticated institutional regulators (USPTO and FDA) and due diligence Trojan-horse interest-conflicted sophisticated investors. This was a Trojan-horse invest-ditch-destroy case connected with the Pfizer Lipitor lawsuit, starting when FDA pointed that it could cause diabetes and Theranos proposed using micro fluid testing to detect Adverse Drug Reaction.

Smear articles against Theranos/Holmes followed at Wall Street Journal, controlled by Rupert Murdoch News Corporation, advertiser for “Scott” Ian Read Pfizer CEO and Forbes article of Scott Gottlieb, than appointed to FDA by Donald Trump who received millions in donations from Pfizer, than appointed Gottlieb to their board, proving quid-pro-quo exchange of advantages/causation. FDA changed position and supported the supposed “faulty” lab/device tests.

Micro fluid tests are around since 70s with around 70% precision versus 80% precision but with a lower cost. Multiple tests could raise its accuracy to around same as macro fluids. Pharmas chemical products average 20%-40% efficacy in controlled clinical trials and less 20% probable effectiveness/efficiency in long term real world use, which pharmas should but do not want to and are not made to measure and Theranos/FDA were on track to do it with micro-fluidics on an individual basis. This process did not depend on the “invention” of any device but only on logistics of mass testing by own or outsourced lab/device.

Immediate release of Elizabeth Holmes and restoring full operation of Theranos is sought at projected market value in 2025 from initial anti-competitive attack in 2015. US$10 billion (damages/market value at time of anti-competitive attack) to 100 billion dollars (x10 non-cooperating fine and 100-200 estimated valuation 10 years after attack) to be paid by News Corporation (Wall Street Journal, Fox News)/Rupert Murdoch (also attacker of rivals Vivendi Universal and destroyer My Space) and Pfizer, CEO/Chairman Ian Read (also attacker-partner of Ranbaxy, Moderna, AstraZeneca, Novavax, BioNTech).

US$10 million in damages from executors Scott Gottlieb (the economist turned, turned doctor, turned Forbes Theranos article bashing, turned FDA director, turned Pfizer board director) and John Carreyou (sensationalist for hire journalist with stunts at attacking News Corp competitor Vivendi Universal/Jean-Marie Messier CEO and Medicare, than Theranos attacker, a company with 100 million in investments from the boss, Murdoch, that hired him).

The false narrative of civil and criminal lawsuits of an alleged “faulty” commonly available technology was a smoke screen for the true factual timeline of use of micro-fluid technology for Adverse-Drug-Reaction continuous and individual mass testing that would prove that Zoloft and Lipitor caused collateral side effects and/or had a placebo like effect, as probably most of pharmaceuticals used in the market, specially in a continuous high/frequent use attacking symptoms instead of causes in a bio-systemic way instead of a mono-chemical silver-bullet way.

The attack on Theranos/Holmes and FDA originated in factual timeline by Zoloft/Lipitor Pfizer lawsuits, when FDA pointed the diabetes side effect of Lipitor and Theranos/Holmes, Edison device patent pointed targeting Pfizer Lipitor for Adverse-Drug-Reaction micro-fluid continuous-individual testing. Zoloft/Lipitor must be fully micro-fluid tested as was planned by FDA/Theranos with Pfizer paying for restitution from their historic profits for confirmation of studies, rejected in court as supposedly being narrow. The attack on Theranos attempt to discredit these tests preemptively. Estimated damages based on preliminary profits/test surpass US$40 billion.

This is an anti-trust anti-competitive case, with nothing to do with fraud, a premeditated false narrative to discredit a competitive threat. Alleged defrauded parties were highly knowledgeable sophisticated investors and institutions. Alleged "faulty" technology/intellectual properties/goals were fully disclosed, available to the general public on line via USPTO patents and web site information. Microfluid health test technology is known, proven, used and effective specially for per-sympthomatic use, since 1980s, with many products in the market, while more expensive and 10% more precise macrofluid testing is usually recommended to symptomatic patients. However multi-microfluid test from different parts of the body (as finger, toe, belly) and/or different time frames can reduce/eliminate/surpass that difference.

The goal of reducing the gap between them does not, if not accomplished, reduce the excellent cost-benefit of bio-microfluid tests with efficiency/effectiveness double than average pharma/chemical products. Bio-microfluid tests average 70% efficiency versus bio-macrofluid 80%, while chemo/pharma products have average efficacy (clinical trial controlled test) of 20%-40%, while efficiency/effectiveness in real world in under 20% after medium/long collateral effects are measured or ZERO after real world data concludes that it is no better than a neutral placebo. FDA/Theranos announced targeting Pfizer Lipitor after data suggested diabetes as a collateral effect and placebo-like effect for cholesterol control. The burden of proof in on the pharma producer to show not only theoretical and empirical clinical trial efficacy above 50% but also efficiency in real world tests which micro fluid tests would enable given its low cost and real time repetition logistics.

The attack on full/general low cost testing (and vaccination) is an attack on preventive health care, a premeditated attack on civilian population, a CRIME AGAINST HUMANITY, for high profit motive, of high cost, non curative, symptomatic health care, from drug, chemical based industry.
By definition a bio-system does not respond well to under/over doses, seeking to correct the dose by micro/macro fluid processes, with overdoses getting stuck in the body generating collateral effects which is a routine in post clinical trial approved drugs. But once the money/profits flow in, it can be used to bribe directly or indirectly politicians, that appoint regulators and judicial agents, and also these ones can be bribed quid-pro-quo advantages prior or after the damaging event.

Low cost, full, general testing/vaccination eradicates diseases with non-patented, natural processes and generate low/average profits/surplus for health organizations. All above average profits must be used for restitution to patients/citizens. All assets of controlling executives and shareholders must be seized to pay for damages and fines. Judicial Administrative Take Over must be used to secure damages and avoid continuation of damages, obstruction of justice and to place the organization on pathway of preventive/cause eradication, low cost health care.

Factual context is of anti-competitive attack on low cost full testing/vaccination and specifically the example of anti-competitive attack of Pfizer/Ian Read and News Corp/Rupert Murdoch on Micro fluid testing Theranos/Elizabeth Holmes, under the objective specific case of Pfizer Lipitor, with FDA warning, +2000 lawsuits/studies for collateral diabetes and studies showing collateral/placebo effect, lack of comprehensive mandatory real world effectiveness tests, which were exactly going to be performed by the micro fluid technology for its low cost high accuracy. So it was crucial motivation for anti-competitive forces to discredit micro fluid testing by attacking the leading player in the market in terms of valuation and strategic partnerships, that turned out to be “trojan-horse” competitor-investors, serving as the back-up plan for the 3 failed attempts by Pfizer to “partner” with Theranos. Walgreen's was a distributor of Pfizer products, News Corporation WSJ/Fox, published articles against Theranos and received ad dollars from Pfizer 3 billion budget.

Current false, subjective, unsubstantiated narrative, culminating for example with an employee of Pfizer testifying about an unauthorized use of a logo of Pfizer in a report, as if to prove that the CEO of Walgreens was being fooled/defrauded by Theranos/Holmes in their partnership to use micro fluids to test or Adverse Drug Reaction, including on Pfizer's Lipitor. The articles on Wall Street Journal and Forbes were copied and pasted by prosecution, that did not investigate the full scope of evidence in the case, leading to shut-down of Theranos, imprisonment/fine on founder without objective factual truthful time line of anti-competitive events, leading prosecutor to bring the actual attacking competitor as witness against the attacked enterprise.

Theranos had its technological competence endorsed by other enterprises using the same technology, United States Patent Office issuing 859 patents that could be examined and “pier reviewed”, Federal Drug Agency that was supporting Theranos and attacking Pfizer, until election changed the director who was a critic of Theranos following the WSJ article with a Forbes article to land him the job at FDA and after at Pfizer board, and finally due-diligence of sophisticated investors running accounting/technological audit for their investments. Rupert Murdoch invested than denounced the invested, claiming the Theranos CEO asked him to remove/retract article, while he altruistically destroyed his own investment later recouped by judge who awarded his 125 million investment back, while at the same time he was receiving ad money from Pfizer's 3 billion annual budget.

False-exaggerated-sensationalist pseudo-scientific narrative against micro-fluid testing, Theranos and Elizabeth Holmes was planted by sensationalist journalist, John Carreyou, previously running attack article Vivendi Universal/CEO Jean Messier, competitor to News Corp/Rupert Murdoch, boss of Carreyou at WSJ and also against Medicare for alleged overpricing in non-pharma procedures, in line with pharma-advertiser News Corp with brands as WSJ and Fox. Article was followed by copy and paste prosecution, running narrative on subjective opinion of interest/emotional conflicted individuals, as intern jealous recent undergrads (lab/research assistants) questioning statistic methods of their PHD colleges, window of former PHD Chief Scientist of Theranos, dogmatic/lazy/jealous/dogmatic academic professors, claiming Elizabeth Holmes (a former Stanford Chemistry student, abandoning inefficient health chemo-paradigm to pursue practical bio-medics technology), did not have “pier review articles”, while 859 public patents and web site detailed applied technology article/information was available for constructive criticism.

Subjective opinions about "faulty" technology are unfounded, when micro fluid technology is available since 80s, with many common applications developed, running high 70% effectiveness, against 80% for macrofluids and under 20% effectiveness for most pharma-industry applications. Includes Pfizer Zoloft and Lipitor, the drug specifically targeted as example of Adverse Reaction Drug to be tested by micro-fluids, application not possible with macro-fluids, given need for daily, weekly, monthly less invasive needs. Pharma drugs have long term collateral effects and placebo-like effects that need to be taken into proper measurement, to reach an effectiveness/efficiency ratio as opposed to the efficacy described in a test controlled by the drug producer and hired testers paid by them, under supervision of regulators led by a FDA director appointed by politicians usually financed by pharma-industry, with drug testing targeted by the mass test/machine/wellness centers logistics being created by Theranos.

Sensationalist journalist weak-link targeted/key whistle blowers/witnesses are the least qualified. Recent undergraduates of Biology Erika Cheung and Tyler Schultz were working months at Theranos as lab/research assistants. Tyler benefiting from nepotism, as grandfather George Schultz sat at board and was an investor, siding with Holmes instead of Tyler, after hearing both sides of story. Experienced sensationalist journalist, John Carreyou, approached weakest links of company, in addition to the distressed widow of cancer/suicide death Chief Scientist Ian Gibbons, feeding the premise that there was something wrong with Elizabeth Holmes and Theranos. Being a journalist for the Wall Street Journal and speaking with people that had no or recent ties makes them vulnerable to prejudice and to seek problems were they previously saw none. Tyler claims that average results were manipulated by removing divergent results, when given that blood is a non-homogeneous liquid in constant change from entry-exit of substances, eliminating high diverging results from majority clustered average results is statistically desirable, as reflects closer the current state of the blood. Opinions diverge between employees that were University Professors, PHD/Doctoral degree, highly trained in statistics, as opposed to a recent undergrad of biology, lowly trained in advanced statistics, although common sense was enough to understand the process of blood sample reading, by definition variable, non-precise, but at a high 70% accuracy compared with average 30% dominant pharma efficiency.

Erika Cheung claimed that lab was not well run, yet she was hired with other highly qualified staff, including chiefs of lab, with PHD and University lab leadership experience to do just that, although the company need problem solvers not bureaucrat wieners. If there were lab problems at Theranos they would be responsible, so they could either be fired, take responsibility or blame management that would if aware of it blame and fire them. The 3rd lab director Kingshuk Das hired in 2016 to fix supposed problems, also did not solve them as also did-not ex qualified lab directors, shifting the blame to the management that is hiring them to find and fix the problems. The lab director said his boss gave implausible excuses to supposed absurd results that he was hired to fix and blamed his boss and alleged unsuited machines. These supposed absurd results would actually be indicative of possible sabotage, given level of hostility/jealousy demonstrated by these recent hires. The entrepreneurial-dynamic problem solving environment of a start-up simultaneously developing a service and a product was not suited for bureaucratic big corporate, university, government individuals looking to get in at the wrong stage of enterprise development.

The key reasonable/correctable mistake of management could be of not distinguishing between hiring conservative bureaucratic non-creative staff to run an existing service, as opposed to hiring entrepreneurial creative innovative risk takers to develop a new service and product at the same time, under intense scrutiny and competitive stress. There was no conflict and it was/is common business practice to use your own lab/service, own device/product, third-party lab/device depending on demand and on the need to double check developing service/product with third party service/product. Completely naive of these recent hires, interns/undergrads lab/research assistants and lab/research chiefs, that joined not from the beginning, but on the hype of successful start-up, with potential high options pay day, to complain and expect problems to be solved for them, as opposed to them solving it, since they are the technical staff, while they are complaining to the managing staff who is hiring them and can fire them. But when the management was under attack by big media journalists, regulators, politicians and/or justice agents, they very quickly sided with their own interests against management to protect themselves, shifting the blame to others, when in fact it was their responsibility if in fact there ware problems. But getting technical staff to testify that a technical problem was actually the fault of the management staff that hire them to solve those problems, is not a believable, legal line of reasoning blame unless there is the threat of power to establish the truth.

Chief Scientist Ian Gibbons (died apparently of suicide under cancer) and Board member Channing Robertson, both PHDs were full supporters of Elizabeth Holmes and of the micro fluid technology that exists since 1980s, is used by many enterprises/consumers. Subjective notion that this technology was “faulty” under this particular enterprise, is a manipulation of the public/juror opinion, since blood testing is by nature diverse, with high 70% but not perfect 100% precise, because blood is a non-homogeneous dynamic substance with varying composition, that is better evaluated by multiple readings, where some will be by nature divergent in certain point in time or place of retrieval from body, not by failure of the reading process. A less invasive method can give daily/weekly/monthly repetition, key for continuous dynamic testing, capable of showing what is really going on with human body.

Macro fluid tests can take place in addition to micro fluid tests, if patient is symptomatic/positive or on an annual check-up non-symptomatic basis. However in the case of Adverse Drug Reaction tests, which was one of the main areas of targeting for Theranos, micro-fluid-testing was/is/will be more advantageous then macro-fluid given it is less invasive, allowing more time-frame repetition to establish an individual history of testing for the patient to an individual substance/pathogen. One of the targets named by Theranos in 2015 was Pfizer Lipitor, named by the FDA as possibly causing diabetes, specially under long/frequent/high dosages, expected when the producer as Pfizer budgets around US$3 billion for advertising and millions for lobbying politicians, that appoint regulators and pay/promote prosecutors/judges that may have previously defended big corporations, including big pharma, including Pfizer.

Theranos mini lab is just the miniaturization and modularization of tests/equipment in use, with possible addition of detail innovations claimed in public patents, none of which were never analyzed/criticized by the unfounded non-objective accusers. It is mainly a logistics innovation to make viable mass testing, with beneficial impact for public health and Human kind. But not good news for the inefficient drug industry, with their low average faulty/low efficacy chemical products, lacking effectiveness/efficiency studies, diverging with the biological systemic nature of the human body, where competing low invasive bio-medicine methods have over double the efficiency in the 80% level versus 30% average for chemo-medicine that seek artificial patents for monopoly short-term profiteering. Also bad news for the entertainment/pseudo-performance highly unhealthy drug industry, where mass market micro-fluid tests can be used to suppress demand as it has been used in the sports industry.

Micro fluid testing has the advantage of allowing many small samples from different times/areas of body, to be tested on different machines/labs, finding an average, eliminating diverging results for a liquid/substance under testing that is by nature non-homogeneous. Diverging results are natural and micro-fluid tests usually have a 70% efficiency versus and 80% for macro fluids. The more samples from different areas/times, tested in different labs/equipment, the more gets closer or can surpass the precision of macro fluids, in an analysis that is by nature dynamic in time. The narrative of treating human blood as if it has a precise reading is completely unscientific, unrealistic and unnatural. The efficiency however in these bio-medical techniques are more than double those observed in pharmaceutical-chemical medicine which average around 30%, way below the 70-80% efficiency observed in blood testing. Trying to discredit a 70/80% efficiency test from Theranos on an alleged 30% clinical trial efficacy Pfizer Lipitor is unreasonable. The testing would determine on an individual basis the real world efficiency of Lipitor in reducing human/digested cholesterol and side effects as diabetes, Adverse Drug Reactions or No action (placebo-like) results.

Since 1980s micro-fluid tests are recommended to non-symptomatic patients, while a symptomatic patient would be better off, using a more efficient/precise as compared to 1 sample of micro-fluid, but more costly and invasive macro-fluid test. However multi-sampling can make micro-fluid equal or more efficient than macro-fluid, by taking samples from different areas of body at different time intervals. But micro fluid test is unique in offering individual, continuous sampling for Adverse Drug Reaction or No Drug Reaction tests, specially for most pharmaceuticals with low efficacy clinical trial results, associated collateral effects and/or no-effect placebo-like real world results. This was one of the main applications described in Theranos mini-lab machine public patent available on internet with easy search in 2015, promising to use it to ADR/NDR drugs, specially naming Lipitor, Pfizer's best selling drug, as main target, as over 2000 lawsuits in 2014 had been filed, after FDA warned in 2012 that it could cause diabetes.

Main prosecutors of the Theranos/Elizabeth Holmes worked for Law firms that worked before and after this case for big pharma clients, including Pfizer, including major multi-billion acquisition Pfizer deals. The conflict of interest associated to the bias behavior/analysis/conclusion on its own voids their participation as neutral judicial agents and voids the indictment, trail and conclusion. They literally worked to destroy the company that refused 3 times Pfizer's so called “partnership” offers, nothing more than an disguised anti-competitive acquisition attempt tailored to minimize damage from a refusal from the company that targeted Pfizer best selling drug Lipitor for Adverse-Drug-Reaction or No-Drug-Reaction individual testing. After the case the main prosecutor ex-employer/partner law-firm landed acquisition multi-billion deals from Pfizer, while the other main prosecutor went to work for a law firm working for big pharma, including Pfizer. New FDA director who had bashed Theranos on Forbes article in 2016 went then to be nominated to the position of FDA director and later after delivering a change of position of FDA towards Pfizer and Theranos, joined Pfizer's board of directors. These conflicted interested parties with quid-pro-quo advantages on their own void the indictment, trial and sentence, mandating in immediate release form prison of Elizabeth Holmes, plus damages and 10 times fine, given the evidence of anti-competitive action and validity of technology and enterprise effort to benefit consumers and society.

Pfizer cost of acquiring to destroy Theranos would be north of US$10 billion. Infiltrating trojan horse investors as Pfizer distributors (Walgreens, Safeway, Walmart), Pfizer shareholder-investors (Partner Fund Management), Pfizer-Advertisers (News Corp) could make it cheaper. The cheapest of all would be simply to shut it down, attacking not only Theranos but the whole concept of micro fluid testing drugs as fraudulent/inefficient/faulty. Efficiency/effectiveness real world tests, in terms of placebo like effect and Adverse Drug Reactions, as for Pfizer's Lipitor/Zoloft, would help accusers in thousands of lawsuits, buried with the excuse that studies, doctors, patients, clinical trials and theoretical flaws were not enough. Micro fluid testing would also allow replacement/advancement of illegal/damaging drug industry controlled placebo/drug clinical trials, replaced by individual/gradual growing number of patients, tested in frequent, less invasive, micro fluid process, including blood, saliva, urine, sweat, congestion.

Articles, law suits, criminal charges, accusation witnesses subjective complaints/opinions, as patient that took micro fluid test, when doctor requested a macro fluid blood test, alleging supposed equal effectiveness, widow of ex-chief scientist (died of cancer/suicide), ranting of her dislike of her husband's partner, while ignoring his professional colleague that praised their work; investors allegedly fooled by logo Pfizer in reports; projection of sales based on firm contracts alleged to be false sale reports; percentages of tests run on proprietary machines versus subcontracting as if being a means of deception while it is common in every industry to do in house or out source activities, depending on demand/supply situation; technically qualified employees hired to run alleged inefficient lab blaming administrative management instead of themselves for what if true was their fault, amount to subjective low quality gossip, easily disproved by market/institutional objective facts available all along. Alleged fraud on sophisticated institutional regulators and investors do not stack up, when all that changed was the allegiance of their leaders after 2016 election and direction of political/judicial power play. At best based on jurisprudence they could have imposed disciplinary fines, about alleged secondary information errors premeditated or not. All/most male CEOs of start-ups in similar misrepresentation allegations were punished with fines and replaced, but none/rarely if there is a case, they were sent to jail on fooling institutional/sophisticated investors with more knowledge, analysis infrastructure then the entrepreneur being accused. The opportunity to validate technology/management skills was present all along, invalidating a unfounded deception/fraud allegations.

The actual truth, based on conflicting interest investigation of participating parties, proves a complete different history to the mainstream story propagated in mass media. This case is instead, an anti-trust, anti-competitive case, where the leading organization of an obsolete technology paradigm, attacks the leading competitor of the new lower cost, higher performance technology paradigm. Micro-fluid testing was going to and will in the near future reduce/eliminate a theoretically and empirically flawed chemical-pharma technology paradigm, generating no or collateral effects, with less than half the efficiency of biomedical techniques. This is a Pfizer/Ian Read and News Corp /Rupert Murdoch against Theranos/Elizabeth Holmes case as factual time-line show. The discrediting of micro fluid testing, followed an attempt to use it against Pfizer's best selling drug Lipitor, following +2000 law suits that ended gathered in class action with a secondary market South Carolina judge, brother of a corporation CEO. He concluded that medical tests/witnesses against the drug were not sufficient evidence, when the tools were available for the producer, regulator and patients themselves to test individually Adverse-Drug-Reaction using Theranos proposed mass infrastructure for micro-fluid testing. Theranos having proprietary device/lab was secondary to the service offered that could be done in-house and outsourced. Double/triple samples, different test sources are able to improve accuracy from the already high levels of 70% to 80%, macro fluid comparable and beyond.

After fits partnership/acquisition attempt of Theranos in 2009, in 2010 Pfizer gave US$3 million grant to improve curriculum of Stanford School of Medicine (University of Theranos founders/key-executives/researchers/CEO/COO/CTO/board member). Dean Phillip Pizzo (key role in 2002 FDA Pharmaceuticals for children Act promoting pre-clinical/clinical trials in children) said it was an improvement to take grant from Pfizer with supposedly no strings-attached, than practice of taking money for speaking-fees and paid-expense trips. Pfizer has made multi million dollar donations to Stanford to present day. In 2015 Marc Tessier-Lavigne leaves the board of Pfizer to be nominated in 2016 to the Presidency of Stanford University. 2015 Theranos requests patent for mini-lab citing Pfizer all time best selling drug Lipitor as target for its Adverse-Drug-Reaction, 17 days later John Carryou working for Pfizer-Advertiser NewsCorp/WSJ writes counter-attack article against Theranos. Whistle-blower Tyler Schultz, grandson of Theranos investor George Shultz (MIT PHD in Industrial Economics, that includes analysis of competing industrial technology paradigms), after 8 months working at Theranos, gets job of Researcher at Stanford University in 2015. 2017 he leaves Stanford and is co-founder of Flux Bio-sciences and in 2022 Heathyr.co competitors of closed-down Theranos/Holmes, enterprise/entrepreneur he denounced, sought competing funding and was never forgiven (never spoke again) by Grandfather Shultz who after listening to both sides, sided with Holmes/Theranos. 2023 President of Stanford Marc Tessier-Lavigne exposed for crucial evidence photo editing on his past research, lab-members blamed, but President steps-down.

2021 Pfizer pays Disney NatGeo to develop documentary about themselves and how they created a vaccine to save the world from Covid (“Mission Possible”). Actually after trying to hostile acquire Moderna they copied their vaccine using a “partnership” shell “German” company founded by Turkish immigrants (BioNTech). In 2022 Disney Hulu launches series Drop Out about Theranos/Elizabeth Holmes with version of Pfizer-advertiser/WSJ article and Pfizer-ex-post-law-firm-associates Holmes-Prosecutors, as the expert company that saw from the beginning “something” was wrong, “faulty” (the exact objective description of what was wrong is still to be found), then they were used, including their logo, to trick investors like 3 Pfizer-distributors (Walgreen, Safeway and Walmart), 1 Pfizer-share-holder (Partner-Fund Management) and 1 Pfizer Advertiser (Rupert Murdoch WSJ/NewsCorp/FoxNews) to Trojan-horse invest in Theranos. They all turned against Theranos/Holmes and their own investment. Probably they taught they could remove Holmes and sell Theranos to Pfizer/Ian Read who actually taught it was cheaper to destroy Theranos for under US$500 million than to partner/buy/destroy it for US$10-20 billion from Holmes (failed), but under US$5 billion if buying from trojan-horse investor controlled Theranos. 2023 as Holmes walks into prison, Prosecutor Robert Leach ex-law-firm-associate-Pfizer-client closed +US$5 billion deal to acquire Global Blood Therapeutics.

Factual year/timeline of chemo-medicine Lipitor Pfizer/Ian Read and Pfizer-advertiser News Corp/Rupert Murdoch acquisition-denied-invest-to-destroy-trojan-horse-attack against Lipitor Adverse Drug Reaction micro-fluid tester bio-medicine Theranos/Elizabeth Holmes

1998-2003 Robert Leach,main Prosecutor of Elizabeth Holmes/Theranos case, works as associate of law firm Latham & Watkins that represents Big Pharma clients, including Pfizer and after Holmes is sentenced/jailed 2022-23, firm closes successful acquisition deals for Pfizer, as US$5.4 billion GBT.
2007 Merck settles US$4,8 billion lawsuit on Vioxx and pulls drug out of market.
(Merck/Vioxx and Lipitor/Pfizer best selling drug mentioned in 2015 Theranos patent ADR Adverse Drug Reaction micro-fluid test targets, coinciding with retaliatory News Corp article on Theranos).
2008 Pfizer settles “partnership” attack on Ranbaxy supposed patent violation/generic “deal” for expiring patent Lipitor a copied statin anti human cholesterol production drug low efficacy drug.
2009 1st Pfizer “exploratory investment”/“partnership”/“service”, acquisition denied by Theranos.
2010 Pfizer donates US$3M to Stanford School of Medicine (University of Theranos founders/CEO/COO).
2012 FDA mandates warning Lipitor can cause diabetes, studies show statin-drugs placebo like.
2013 Merck settles paying 688 million to investors for hiding bad results of statin anti-cholesterol, Vytorin, competitor of Pfizer Lipitor,
2013 2nd Pfizer “partnership” offer for Theranos/Walgreens/Wellness Center distribution point.
2014 Pfizer Zoloft placebo-like lawsuit ends with Judge Lucy Koh (future Theranos Judge) 4 year statute of limitations, class action denial, 7 months over from purchase receipt, despite evidence.
2014 Pfizer Lipitor USA +2000 case lawsuits/class action consolidated in small South Carolina, 14 cases filled there, to Judge Richard Gergel, brother of a corporation CEO, later dismissing case.
2014-15 News Corp/Rupert Murdoch, Pfizer advertiser, invests US$125M in Theranos, most valuable bio-tech start-up. He had also invested-destroyed MySpace, most-valuable media start-up.
Pfizer distributors (Safeway/Walgreens/WalMart) and Pfizer investors also invest to latter attack.
2015 FDA approves Theranos low cost Herpes test and large test pipeline close to approval.
2015 3rd and final Pfizer offer for “partnership” with Theranos at Wallgreen Wellness Center.
2015 (Sept 28) Theranos/Holmes Adverse Drug Reaction test microfluid minilab patent mentions Pfizer/Lipitor as target.
2015 (Oct 15) Pfizer-advertiser WSJ/Carreyou/NewsCorp/Murdoch runs article attacking his own trojan-horse investment at Theranos. Carreyou is same Journalist that wrote article attacking Vivendi Universal/CEO Jean Messier, rival competitor of News Corp.
2015 Pfizer/CEO Ian Read, Scottish, record 3 billion ad budget runs ads on WSJ/Fox news/NewsCorp.
2015-16 Marc Tessier-Lavigne leaves Pfizer board and becomes President of Stanford University.
2015-16 Tyler Schultz 8 months undergrad Theranos researcher whistle-blower hired as Stanford researcher.
2016 Scott Gottlieb, economist/doctor/future Pfizer board, writes article on Forbes attacking Theranos/FDA.
2016 Elizabeth Holmes/Theranos hosts fundraiser to support Hillary Clinton, Democrat, with agenda of controlling price gouging drug industry. Pfizer countered by claiming they had funded polling favorite Hillary with 400k, while Trump with only 100k, post-election that was inverted to 5:1 pro-Republican.
2016 Elected President Donald Trump, receives Pfizer multi-million donations, as US$1 million for inauguration, US$1 million 4 ticket “leadership luncheon”, conducts multi-billion deals with Pfizer.
2017 Scott Gottlieb named FDA Director by Donald Trump. FDA, Medicare, DOJ, federal government Trump appointees, shift to hostile position against Theranos and friendly to Pfizer.
2017 Tyler Schultz whistle-blower co-founds Flux Bio-sciences product/funding competitor to Theranos.
2018 Elizabeth Holmes indicted, Theranos shut down, IP taken by Softbank for US$100million as collateral of loan. Pfizer employees used as witnesses against rival Theranos, citing unauthorized use of Pfizer logo on report to supposedly fool Walgreen/News Corp CEOs into investing in Theranos. Pfizer did invest US$1M as “exploratory investment” then turned into “disappointing service fee”.
2017-2018 Lipitor class and appeal action dismissed consolidated in South Carolina under conservative judge Richard Gergel, the judge with corporation CEO brother, scientific evidence ruled insufficient, while Theranos offered low cost ADR method to verify collateral/placebo effects.
2019 Scott Gottlieb critic than persecutor of Theranos leaves FDA to be Pfizer board director.
2020 Pfizer fails to “partner”/acquire Moderna and AstraZeneca then “partners” with BioNTech, to copy/compete with Moderna mRNA vaccine and with AstraZeneca DNA vaccine, technology bashed on press and social media, as inactive virus vaccine Coronavirus, all Pfizer competitors.
Pfizer gets warp speed COVID vaccine contract from Donald Trump, “partnering” for “cheaper” vaccine with mRNA public funded research vaccine, earning patent for name lipid-nano-particle a direct copy from a natural occurring exosome mRNA. “cheaper” US$10-20 dose contract,
World Health Organization estimated vaccine average cost in US$0.84 cents and 200 labs available.
2021 Pfizer pays Disney NatGeo to develop Pfizer documentary about how they supposedly created vaccine to save the world from Covid (“Mission Possible”), or after trying to acquire Moderna, copied their vaccine.
2022 Disney Hulu launches series Drop Out about Theranos/Elizabeth Holmes with version of Pfizer-advertiser/WSJ article and Pfizer-ex/post-law-firm-associates Holmes-Prosecutors.
2022 Theranos/Holmes shut-down/sued/prosecuted and sentenced 13 year jail time, US$450M fine and 125 million payment do Murdoch/NewsCorp. Judge Edward Davila, replaced previous Lucy Koh, judge burying Pfizer/Zoloft case, gave sentence. Same Judge previously sentencing woman for close to 10 years in prison over a Wendy's chili sauce, defamed unnecessarily by judicial agents and journalists spreading information on case, not the woman who frivolously, fraudulently or justly tried to sue Wendy's, a corporation similarly also pursued for unwanted acquisition from later succesful holding company of rival Arby's.
2022-23 As Elizabeth Holmes is sent to prison law firm having Pfizer as client, where her Prosecutor Robert Leach was associated for 5 years, Latham & Watkins, collected probably hundreds of millions to advise on Global Blood Therapeutics US$5.4 Billion acquisition by Pfizer. Latham & Watkins also advises Zentalis Pharmaceuticals on US$25 Million Equity Investment from Pfizer. Meanwhile, her other prosecutor Jeff Schenke became partner at Law firm Jones Day a big tobacco/big pharma, including Pfizer, litigator/adviser for drug industry.

Theranos/Elizabeth Holmes Defenders with conflict of interest connected to competitor Pfizer explaining poor defense avoiding conflict with Pfizer. Boies Schiller Flexner (2016, ended defense for disagreements of legal strategy; participated in 2021 EpiPen US$345 million settlement with Pfizer). Law Firm Cooley LLP (2019 withdrawed from defense alleging Holmes would not have money to pay them; 2021 closed acqusition deal for Pfizer of Arena Pharma of 6.7 billion); Williams & Connolly (defending Holmes; 2022 defended Pfizer in +50k cases of Pfizer antiacid Zantac for causing cancer).

Essentially the drug entertainment and drug medicine industry has an under 20% efficiency chemo-medicine technology, while Theranos is a bio-medicine technology with over 80% efficiency. Single-sample micro fluid exams have around 70% accuracy, less invasive, recommended for non-symptomatic preventive/testing exams, but multi-samples (different body local/time) can surpass 80%. Human micro/macro fluids exams/machines are not “faulty”, they are by nature dynamic, with input/output change, in constant time and body location change. Theranos had bio-industry awards, 859 patents granted, FDA tests approved/to be approved, intended to conduct micro-fluid testing for pathogens and Adverse-Drug-Reaction short/long term studies including on Pfizer Lipitor and other inefficient/collateral effect/placebo like effect drugs. Also to be used as health substance abuse tests as more efficient/fast/repetitive condition of employment, insurance, licenses and tax deduction, creating potentially a big revenue/profit drop for drug industry.